Pharmaceutical companies call for more deregulation

Published: 2011-02-21 06:58:00

Updated: 2011-02-21 06:58:00

Domestic drug manufacturers have asked the government to ease drug related regulations, such as scope of toll manufacturing and bioequivalence, and heavy fines.

In a recent meeting with officials from the Korea Food and Drug Administration, pharmaceutical chief executive officers demanded the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK